Transplantation of Multipotent Hematopoietic Stem Cells Market size was valued at USD 7.1 Billion in 2024 and is projected to reach USD 12.5 Billion by 2033, exhibiting a CAGR of 7.2% from 2026 to 2033.
The transplantation of multipotent hematopoietic stem cells (HSCs) in South Korea has witnessed significant advancements, positioning the nation as a key player in the global stem cell market. HSC transplantation, a critical procedure for treating various hematological disorders, has seen increased adoption due to its therapeutic potential and the rising prevalence of such conditions.
In 2023, South Korea's adult stem cell market, which encompasses HSCs, generated a revenue of USD 140.2 million. Projections indicate that this figure will escalate to USD 417.4 million by 2030, reflecting a compound annual growth rate (CAGR) of 16.9% from 2024 to 2030. Notably, hematopoietic stem cells emerged as the predominant segment within this market, underscoring their pivotal role in therapeutic applications.
The broader stem cells market in South Korea also demonstrates robust growth. In 2024, the market revenue stood at USD 219.0 million and is anticipated to reach USD 538.1 million by 2030, with a CAGR of 16.2% from 2025 to 2030. This surge is attributed to the escalating demand for regenerative therapies and the nation's commitment to biotechnological innovations.
Several factors contribute to this upward trajectory. The increasing prevalence of hematological disorders necessitates advanced treatment modalities, propelling the demand for HSC transplantation. Additionally, South Korea's supportive regulatory framework and substantial investments in biotechnology research have fostered an environment conducive to market growth.
Industry requirements have evolved in tandem with market expansion. There is a pronounced emphasis on stringent quality control measures to ensure the safety and efficacy of stem cell therapies. Moreover, the integration of cutting-edge technologies, such as gene editing and personalized medicine, has become imperative to meet the diverse needs of patients and enhance treatment outcomes.
In the realm of cell therapy, South Korea's market is projected to grow from USD 368.0 million in 2023 to USD 1,399.3 million by 2030, marking a CAGR of 21% from 2024 to 2030. Autologous therapies, wherein patients receive their own cells, have been the largest revenue-generating segment. However, allogeneic therapies, involving donor cells, are gaining traction due to advancements in immunological compatibility and graft-versus-host disease management.
The regenerative medicine sector further exemplifies South Korea's dedication to medical innovation. With revenues expected to rise from USD 399.7 million in 2023 to USD 1,288.1 million by 2030, and a CAGR of 18.2% from 2024 to 2030, the market reflects the nation's commitment to developing therapies that restore or establish normal function through cell-based treatments.
In conclusion, South Korea's transplantation of multipotent hematopoietic stem cells market is on a dynamic growth path. Driven by increasing medical needs, supportive policies, and technological advancements, the industry is poised to make significant contributions to global healthcare. As the market evolves, continuous focus on quality assurance, innovation, and patient-centric approaches will be paramount to sustain this momentum and address the complex challenges inherent in stem cell transplantation.
Get an In-Depth Research Analysis of the South Korea Transplantation of Multipotent Hematopoietic Stem Cells Market Size And Forecast [2025-2032]
Â
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Transplantation of Multipotent Hematopoietic Stem Cells Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Transplantation of Multipotent Hematopoietic Stem Cells Market
Autologous Stem Cells
Allogeneic Stem Cells
Umbilical Cord Blood Stem Cells
Induced Pluripotent Stem Cells (iPSCs)
Oncology
Hematologic Disorders
Metabolic Disorders
Autoimmune Disorders
Cardiovascular Diseases
Bone Marrow
Peripheral Blood
Umbilical Cord
Other Sources (e.g., adipose tissue, dental pulp)
Stem Cell Transplantation
Gene Therapy
Cell-based Immunotherapy
Hospitals
Research Institutions
Biotechnology Companies
Blood and Bone Marrow Banks
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Transplantation of Multipotent Hematopoietic Stem Cells Market Research Analysis
1. Introduction of the South Korea Transplantation of Multipotent Hematopoietic Stem Cells Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Transplantation of Multipotent Hematopoietic Stem Cells Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Transplantation of Multipotent Hematopoietic Stem Cells Market, By Type
6. South Korea Transplantation of Multipotent Hematopoietic Stem Cells Market, By Application
7. South Korea Transplantation of Multipotent Hematopoietic Stem Cells Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Transplantation of Multipotent Hematopoietic Stem Cells Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/